COGNEX CORP (CGNX) Stock Fundamental Analysis
NASDAQ:CGNX - Nasdaq - US1924221039 - Common Stock - Currency: USD
CGNX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. CGNX has an excellent financial health rating, but there are some minor concerns on its profitability. CGNX is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CGNX was profitable.
In the past year CGNX had a positive cash flow from operations.
Each year in the past 5 years CGNX has been profitable.
In the past 5 years CGNX always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of CGNX (6.09%) is better than 79.03% of its industry peers.
CGNX has a better Return On Equity (8.10%) than 69.35% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.98%, CGNX is in the better half of the industry, outperforming 66.94% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CGNX is in line with the industry average of 9.55%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.09% | ||
| ROE | 8.1% | ||
| ROIC | 5.98% |
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
1.3 Margins
The Profit Margin of CGNX (13.13%) is better than 88.71% of its industry peers.
In the last couple of years the Profit Margin of CGNX has declined.
CGNX's Operating Margin of 14.19% is amongst the best of the industry. CGNX outperforms 87.90% of its industry peers.
CGNX's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 67.72%, CGNX belongs to the best of the industry, outperforming 96.77% of the companies in the same industry.
CGNX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.19% | ||
| PM (TTM) | 13.13% | ||
| GM | 67.72% |
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CGNX is destroying value.
The number of shares outstanding for CGNX has been reduced compared to 1 year ago.
The number of shares outstanding for CGNX has been reduced compared to 5 years ago.
CGNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
CGNX has an Altman-Z score of 9.62. This indicates that CGNX is financially healthy and has little risk of bankruptcy at the moment.
CGNX has a better Altman-Z score (9.62) than 87.10% of its industry peers.
CGNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 9.62 |
ROIC/WACC0.64
WACC9.41%
2.3 Liquidity
CGNX has a Current Ratio of 3.29. This indicates that CGNX is financially healthy and has no problem in meeting its short term obligations.
CGNX has a Current ratio of 3.29. This is in the better half of the industry: CGNX outperforms 66.94% of its industry peers.
A Quick Ratio of 2.53 indicates that CGNX has no problem at all paying its short term obligations.
CGNX has a Quick ratio of 2.53. This is in the better half of the industry: CGNX outperforms 66.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.29 | ||
| Quick Ratio | 2.53 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 32.79% over the past year.
Measured over the past years, CGNX shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.03% on average per year.
CGNX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.14%.
The Revenue has been growing slightly by 4.74% on average over the past years.
EPS 1Y (TTM)32.79%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%8.7%
Revenue 1Y (TTM)10.14%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%4.1%
3.2 Future
The Earnings Per Share is expected to grow by 25.50% on average over the next years. This is a very strong growth
CGNX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.22% yearly.
EPS Next Y17.7%
EPS Next 2Y23.05%
EPS Next 3Y23.06%
EPS Next 5Y25.5%
Revenue Next Year5.32%
Revenue Next 2Y7.78%
Revenue Next 3Y8.6%
Revenue Next 5Y2.22%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CGNX is valuated quite expensively with a Price/Earnings ratio of 50.65.
CGNX's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.54, CGNX is valued quite expensively.
With a Price/Forward Earnings ratio of 36.62, CGNX can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CGNX is on the same level as its industry peers.
CGNX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 35.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.65 | ||
| Fwd PE | 36.62 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CGNX.
Based on the Price/Free Cash Flow ratio, CGNX is valued a bit cheaper than 62.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38.34 | ||
| EV/EBITDA | 40.35 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CGNX does not grow enough to justify the current Price/Earnings ratio.
CGNX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CGNX's earnings are expected to grow with 23.06% in the coming years.
PEG (NY)2.86
PEG (5Y)N/A
EPS Next 2Y23.05%
EPS Next 3Y23.06%
5. Dividend
5.1 Amount
CGNX has a yearly dividend return of 0.78%, which is pretty low.
Compared to an average industry Dividend Yield of 1.79, CGNX pays a better dividend. On top of this CGNX pays more dividend than 85.48% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, CGNX's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.78% |
5.2 History
On average, the dividend of CGNX grows each year by 8.39%, which is quite nice.
CGNX has paid a dividend for at least 10 years, which is a reliable track record.
CGNX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)8.39%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
43.88% of the earnings are spent on dividend by CGNX. This is a bit on the high side, but may be sustainable.
The dividend of CGNX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.88%
EPS Next 2Y23.05%
EPS Next 3Y23.06%
NASDAQ:CGNX (8/8/2025, 1:55:58 PM)
41.0272
-0.33 (-0.8%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners102.03%
Inst Owner Change-0.73%
Ins Owners0.27%
Ins Owner Change1.27%
Market Cap6.89B
Analysts76.15
Price Target45.97 (12.05%)
Short Float %3.43%
Short Ratio3.45
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.78% |
Yearly Dividend0.31
Dividend Growth(5Y)8.39%
DP43.88%
Div Incr Years3
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.3%
Min EPS beat(2)3.71%
Max EPS beat(2)18.89%
EPS beat(4)4
Avg EPS beat(4)13.13%
Min EPS beat(4)3.71%
Max EPS beat(4)26.05%
EPS beat(8)8
Avg EPS beat(8)15.9%
EPS beat(12)11
Avg EPS beat(12)18.09%
EPS beat(16)13
Avg EPS beat(16)14.9%
Revenue beat(2)0
Avg Revenue beat(2)-0.67%
Min Revenue beat(2)-0.78%
Max Revenue beat(2)-0.55%
Revenue beat(4)1
Avg Revenue beat(4)-0.13%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)2.05%
Revenue beat(8)4
Avg Revenue beat(8)0.37%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.52%
PT rev (1m)1.75%
PT rev (3m)-4.77%
EPS NQ rev (1m)0.85%
EPS NQ rev (3m)-2.34%
EPS NY rev (1m)0%
EPS NY rev (3m)1.41%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)-2.04%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-1.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.65 | ||
| Fwd PE | 36.62 | ||
| P/S | 7.41 | ||
| P/FCF | 38.34 | ||
| P/OCF | 36.1 | ||
| P/B | 4.57 | ||
| P/tB | 6.78 | ||
| EV/EBITDA | 40.35 |
EPS(TTM)0.81
EY1.97%
EPS(NY)1.12
Fwd EY2.73%
FCF(TTM)1.07
FCFY2.61%
OCF(TTM)1.14
OCFY2.77%
SpS5.54
BVpS8.97
TBVpS6.06
PEG (NY)2.86
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.09% | ||
| ROE | 8.1% | ||
| ROCE | 7.28% | ||
| ROIC | 5.98% | ||
| ROICexc | 6.84% | ||
| ROICexgc | 9.9% | ||
| OM | 14.19% | ||
| PM (TTM) | 13.13% | ||
| GM | 67.72% | ||
| FCFM | 19.32% |
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
ROICexc(3y)9.56%
ROICexc(5y)11.82%
ROICexgc(3y)12.73%
ROICexgc(5y)15.09%
ROCE(3y)9.35%
ROCE(5y)11.55%
ROICexcg growth 3Y-25.69%
ROICexcg growth 5Y-4.75%
ROICexc growth 3Y-29.85%
ROICexc growth 5Y-7.09%
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
F-Score7
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 34.24% | ||
| Cap/Sales | 1.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 115.96% | ||
| Profit Quality | 147.18% | ||
| Current Ratio | 3.29 | ||
| Quick Ratio | 2.53 | ||
| Altman-Z | 9.62 |
F-Score7
WACC9.41%
ROIC/WACC0.64
Cap/Depr(3y)84%
Cap/Depr(5y)75.71%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.9%
Profit Quality(3y)103.13%
Profit Quality(5y)109.22%
High Growth Momentum
Growth
EPS 1Y (TTM)32.79%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%8.7%
EPS Next Y17.7%
EPS Next 2Y23.05%
EPS Next 3Y23.06%
EPS Next 5Y25.5%
Revenue 1Y (TTM)10.14%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%4.1%
Revenue Next Year5.32%
Revenue Next 2Y7.78%
Revenue Next 3Y8.6%
Revenue Next 5Y2.22%
EBIT growth 1Y45.87%
EBIT growth 3Y-28.52%
EBIT growth 5Y-4.2%
EBIT Next Year52.31%
EBIT Next 3Y31.77%
EBIT Next 5Y20.51%
FCF growth 1Y-4.75%
FCF growth 3Y-23.43%
FCF growth 5Y-10.36%
OCF growth 1Y-7.91%
OCF growth 3Y-22%
OCF growth 5Y-10.06%